These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 36441342)
1. The economic impact of comorbidity in multiple sclerosis. Ponzio M; Monti MC; Mallucci G; Borrelli P; Fusco S; Tacchino A; Brichetto G; Tronconi L; Montomoli C; Bergamaschi R Neurol Sci; 2023 Mar; 44(3):999-1008. PubMed ID: 36441342 [TBL] [Abstract][Full Text] [Related]
2. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs. Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457 [TBL] [Abstract][Full Text] [Related]
3. Economic burden of multiple sclerosis in Slovakia - from 2015 to 2020. Babela R; Dugas J BMC Health Serv Res; 2022 Dec; 22(1):1467. PubMed ID: 36461018 [TBL] [Abstract][Full Text] [Related]
4. Estimate of the cost of multiple sclerosis in Spain by literature review. Fernández O; Calleja-Hernández MA; Meca-Lallana J; Oreja-Guevara C; Polanco A; Pérez-Alcántara F Expert Rev Pharmacoecon Outcomes Res; 2017 Aug; 17(4):321-333. PubMed ID: 28726515 [TBL] [Abstract][Full Text] [Related]
5. Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in Sweden. Bütepage G; Esawi A; Alexanderson K; Friberg E; Murley C; Hillert J; Karampampa K Mult Scler J Exp Transl Clin; 2020; 6(4):2055217320968597. PubMed ID: 33149932 [TBL] [Abstract][Full Text] [Related]
6. Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability. Casado V; Martínez-Yélamos S; Martínez-Yélamos A; Carmona O; Alonso L; Romero L; Moral E; Gubieras L; Arbizu T BMC Health Serv Res; 2006 Nov; 6():143. PubMed ID: 17078879 [TBL] [Abstract][Full Text] [Related]
7. Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis. Ruutiainen J; Viita AM; Hahl J; Sundell J; Nissinen H J Med Econ; 2016; 19(1):21-33. PubMed ID: 26360615 [TBL] [Abstract][Full Text] [Related]
8. Economic costs incurred by the patients with multiple sclerosis at different levels of the disease: a cross-sectional study in Northwest Iran. Imani A; Gharibi F; Khezri A; Joudyian N; Dalal K BMC Neurol; 2020 May; 20(1):205. PubMed ID: 32446303 [TBL] [Abstract][Full Text] [Related]
9. Impact of multiple sclerosis comorbidities on quality of life and job activity. Mallucci G; Monti MC; Ponzio M; Borrelli P; Montomoli C; Bergamaschi R Mult Scler; 2024 Jul; 30(8):1047-1055. PubMed ID: 38912795 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors. Marck CH; Neate SL; Taylor KL; Weiland TJ; Jelinek GA PLoS One; 2016; 11(2):e0148573. PubMed ID: 26849357 [TBL] [Abstract][Full Text] [Related]
11. The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study. Drulovic J; Pekmezovic T; Tamas O; Adamec I; Aleksic D; Andabaka M; Basic Kes V; Butkovic Soldo S; Cukic M; Despinic L; Dincic E; Djelilovic Vranic J; Grgic S; Habek M; Hristova SI; Ivanovic J; Jovanovic A; Jovicevic V; Krbot Skoric M; Kuzmanovski I; Maric G; Mesaros S; Milanov IG; Miletic Drakulic S; Sinanovic O; Skarpa Prpic I; Sremec J; Tadic D; Toncev G; Sokic D Front Immunol; 2023; 14():1284031. PubMed ID: 38022568 [TBL] [Abstract][Full Text] [Related]
12. Perceived health- related quality of life in persons with multiple sclerosis with and without a vascular comorbidity. Neto LO; Ruiz JA; Gromisch ES Qual Life Res; 2024 Feb; 33(2):573-581. PubMed ID: 37966685 [TBL] [Abstract][Full Text] [Related]
13. Perspectives in multiple sclerosis health care: special focus on the costs of multiple sclerosis. Rotstein Z; Hazan R; Barak Y; Achiron A Autoimmun Rev; 2006 Oct; 5(8):511-6. PubMed ID: 17027884 [TBL] [Abstract][Full Text] [Related]
14. Burden of a multiple sclerosis relapse: the patient's perspective. Oleen-Burkey M; Castelli-Haley J; Lage MJ; Johnson KP Patient; 2012; 5(1):57-69. PubMed ID: 22217263 [TBL] [Abstract][Full Text] [Related]
15. Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression. Brown LJ; Li J; Brunner M; Snoke M; La HA J Med Econ; 2021; 24(1):140-149. PubMed ID: 33461357 [TBL] [Abstract][Full Text] [Related]
16. Healthcare Cost of Multiple Sclerosis and in Relation to Disability Level in Alberta. McCombe JA; Smyth P; Kate M; So H; Vu K; Luu H; Martins KJB; Aponte-Hao S; Nguyen PU; Richer L; Williamson T; Klarenbach SW Can J Neurol Sci; 2024 Oct; ():1-12. PubMed ID: 39356041 [TBL] [Abstract][Full Text] [Related]
17. Impact on healthcare resource utilization of multiple sclerosis in Spain. Sicras-Mainar A; Ruíz-Beato E; Navarro-Artieda R; Maurino J BMC Health Serv Res; 2017 Dec; 17(1):854. PubMed ID: 29284493 [TBL] [Abstract][Full Text] [Related]
18. A literature review of cost-of-illness studies on the economic burden of multiple sclerosis. Paz-Zulueta M; Parás-Bravo P; Cantarero-Prieto D; Blázquez-Fernández C; Oterino-Durán A Mult Scler Relat Disord; 2020 Aug; 43():102162. PubMed ID: 32442885 [TBL] [Abstract][Full Text] [Related]
19. Quantifying the relationship between increased disability and health care resource utilization, quality of life, work productivity, health care costs in patients with multiple sclerosis in the US. Jones E; Pike J; Marshall T; Ye X BMC Health Serv Res; 2016 Jul; 16():294. PubMed ID: 27443278 [TBL] [Abstract][Full Text] [Related]
20. The increasing economic burden of multiple sclerosis by disability severity in Australia in 2017: Results from updated and detailed data on types of costs. Ahmad H; Campbell JA; van der Mei I; Taylor BV; Zhao T; Palmer AJ Mult Scler Relat Disord; 2020 Sep; 44():102247. PubMed ID: 32554286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]